Dialysis centers backed by DaVita (BBB-) and Fresenius (BBB) continue to trade at 5.5-6.0% cap rates with 10-15 year lease terms. The essential, non-discretionary nature of dialysis services provides recession-resistant cash flows.
This content is for informational purposes only and does not constitute investment advice. Always consult with qualified professionals before making investment decisions.
Get Daily Insights Like This
Join thousands of CRE investors receiving market updates, deal analysis, and tenant intelligence daily.
Subscribe Free